TGTX
TG Therapeutics Inc
Price:  
13.44 
USD
Volume:  
3,680,002.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TGTX EV/EBITDA

-107.3%
Upside

As of 2024-02-23, the EV/EBITDA ratio of TG Therapeutics Inc (TGTX) is -156.63. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TGTX's latest enterprise value is 1,982.95 mil USD. TGTX's TTM EBITDA according to its financial statements is -12.66 mil USD. Dividing these 2 quantities gives us the above TGTX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.0x - 15.7x 13.1x
Forward P/E multiples 17.4x - 19.4x 18.5x
Fair Price (1.11) - (0.97) (0.98)
Upside -108.3% - -107.2% -107.3%
13.44 USD
Stock Price
(0.98) USD
Fair Price

TGTX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-22 -78.57
2024-02-21 -76.11
2024-02-20 -77.34
2024-02-16 -80.85
2024-02-15 -84.18
2024-02-14 -82.95
2024-02-13 -81.43
2024-02-12 -88.74
2024-02-09 -86.17
2024-02-08 -85.58
2024-02-07 -84.01
2024-02-06 -89.74
2024-02-05 -89.50
2024-02-02 -96.22
2024-02-01 -98.68
2024-01-31 -94.94
2024-01-30 -94.53
2024-01-29 -95.00
2024-01-26 -92.37
2024-01-25 -93.42
2024-01-24 -91.61
2024-01-23 -92.42
2024-01-22 -94.82
2024-01-19 -88.10
2024-01-18 -88.51
2024-01-17 -89.44
2024-01-16 -88.62
2024-01-12 -92.19
2024-01-11 -100.67
2024-01-10 -103.88
2024-01-09 -122.82
2024-01-08 -124.52
2024-01-05 -114.87
2024-01-04 -105.34
2024-01-03 -98.85
2024-01-02 -99.61
2023-12-29 -99.85
2023-12-28 -103.01
2023-12-27 -99.67
2023-12-26 -99.32
2023-12-22 -99.38
2023-12-21 -100.26
2023-12-20 -100.61
2023-12-19 -109.96
2023-12-18 -106.34
2023-12-15 -108.03
2023-12-14 -105.23
2023-12-13 -97.57
2023-12-12 -92.02
2023-12-11 -88.92